The store will not work correctly when cookies are disabled.
7-chloro-8-methyl-2-(pyridin-3-yl)quinoline-4-carboxylic acid
ID: ALA4557494
Cas Number: 588696-83-7
PubChem CID: 4339700
Product Number: C336357, Order Now?
Max Phase: Preclinical
Molecular Formula: C16H11ClN2O2
Molecular Weight: 298.73
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1c(Cl)ccc2c(C(=O)O)cc(-c3cccnc3)nc12
Standard InChI: InChI=1S/C16H11ClN2O2/c1-9-13(17)5-4-11-12(16(20)21)7-14(19-15(9)11)10-3-2-6-18-8-10/h2-8H,1H3,(H,20,21)
Standard InChI Key: GJRLWOOMYJFTMN-UHFFFAOYSA-N
Molfile:
RDKit 2D
21 23 0 0 0 0 0 0 0 0999 V2000
13.6432 -13.0957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6421 -13.9152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3501 -14.3242 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3483 -12.6868 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0569 -13.0921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0577 -13.9111 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7662 -14.3181 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4745 -13.9073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.4698 -13.0852 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7606 -12.6818 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.1720 -12.6740 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8825 -13.0800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.5872 -12.6678 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.5827 -11.8497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8675 -11.4457 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1657 -11.8602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.7679 -15.1353 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0611 -15.5454 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.4765 -15.5425 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.3459 -11.8696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9354 -12.6872 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
9 11 1 0
7 17 1 0
17 18 2 0
17 19 1 0
4 20 1 0
1 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 298.73 | Molecular Weight (Monoisotopic): 298.0509 | AlogP: 3.96 | #Rotatable Bonds: 2 |
Polar Surface Area: 63.08 | Molecular Species: ACID | HBA: 3 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.49 | CX Basic pKa: 4.38 | CX LogP: 2.87 | CX LogD: 0.42 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.78 | Np Likeness Score: -1.40 |
References
1. (2018) Methods and compositions for inhibiting cnksr1, |